Prelude Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-44,300
Closed -$403K 1312
2024
Q1
$403K Buy
+44,300
New +$403K 0.02% 654
2020
Q4
Sell
-200
Closed -$2K 1320
2020
Q3
$2K Buy
+200
New +$2K ﹤0.01% 1263
2020
Q1
Sell
-56,164
Closed -$222K 1374
2019
Q4
$222K Buy
+56,164
New +$222K 0.01% 512